Barrett Esophagus Clinical Trial
Official title:
A Controlled, Randomised Multicenter Study Comparing the Effectiveness of EndoRotor (New Treatment Technique) Versus Radiofrequency (Reference Technique) in Treating Barrett's Esophagus Complicated by Dysplasia
Barrett Esophagus is a common pathology, with an estimated prevalence of 1.6% at risk of progression to precancerous mucosa (low to high grade dysplasia). The incidence of adenocarcinoma on BE is 0.5% per year. In the event of dysplasia or cancer in situ, it is currently recommended at international and particularly European level to eradicate BE. The treatment techniques used to date carry out thermal destruction of the BE, in particular by radiofrequency. Eradication of dysplasia is achieved in 81% to 100% and disappearance of BE in 73% to 87% of cases. It requires an average of 3 destruction sessions. RF does not allow histological analysis after destruction of BE, but the risk of progression to neoplasia is estimated at 7.8/1000 persons per year. This risk could be due to the presence of glands buried in the esophageal mucosa. Indeed, these glands are not destroyed by thermal ablation methods, and remain invisible during endoscopic controls. A new treatment technique using the Endorotor® system allows mechanical resection of the entire mucosa in one session of treatment. In addition, the cost of these thermal destruction techniques currently limits their wider diffusion. It is therefore legitimate to propose a less expensive and probably more effective alternative technique.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03554356 -
Nitrous Oxide For Endoscopic Ablation of Refractory Barrett's Esophagus (NO FEAR-BE)
|
N/A | |
Completed |
NCT03015389 -
Wide Area Transepithelial Sample Esophageal Biopsy Combined With Computer Assisted 3-Dimensional Tissue Analysis (WATS3D) For the Detection of High Grade Esophageal Dysplasia and Adenocarcinoma
|
||
Completed |
NCT03434834 -
OCT Pilot in Esophagus
|
N/A | |
Terminated |
NCT04642690 -
Nitrates and IL-8 in Barrett's Esophagus
|
||
Completed |
NCT03468634 -
Raman Probe for In-vivo Diagnostics (During Oesophageal) Endoscopy
|
N/A | |
Recruiting |
NCT02310230 -
An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy
|
N/A | |
Completed |
NCT00217087 -
Endoscopic Therapy of Early Cancer in Barretts Esophagus
|
Phase 2 | |
Completed |
NCT02284802 -
Early Detection of Tumors of the Digestive Tract by Confocal Endomicroscopy
|
N/A | |
Recruiting |
NCT05530343 -
Seattle Biopsy Protocol Versus Wide-Area Transepithelial Sampling in Patients With Barrett's Esophagus Undergoing Surveillance
|
N/A | |
Active, not recruiting |
NCT04151524 -
Classification of Adenocarcinoma of the Esophagogastric Junction
|
||
Completed |
NCT00955019 -
Novel Method of Surveillance in Barrett's Esophagus
|
Phase 2 | |
Terminated |
NCT00386594 -
Pilot Study of Oral 852A for Elimination of High-Grade Dysplasia in Barrett's Esophagus
|
N/A | |
Completed |
NCT00576498 -
Novel Imaging Techniques in Barrett's Esophagus
|
N/A | |
Completed |
NCT02688114 -
Healing of the Esophageal Mucosa After RFA of Barrett's Esophagus
|
N/A | |
Recruiting |
NCT06071845 -
Assessment of a Minimally Invasive Collection Device for Molecular Analysis of Esophageal Samples
|
N/A | |
Completed |
NCT02560623 -
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
|
N/A | |
Recruiting |
NCT05056051 -
Wide-Area Transepithelial Sampling in Endoscopic Eradication Therapy for Barrett's Esophagus
|
N/A | |
Recruiting |
NCT04001478 -
Non-invasive Testing for Early oEesophageal Cancer and Dysplasia
|
||
Completed |
NCT03859557 -
The Evaluation of Patients With Esophageal and Foregut Disorders With WATS (Wide Area Transepithelial Sample With 3-Dimensional Computer-Assisted Analysis) vs. 4-Quadrant Forceps Biopsy
|
||
Completed |
NCT04587310 -
Does Laparoscopic Sleeve Gastrectomy Lead to Barrett's Esophagus, 5-year Esophagogastroduodenoscopy Findings: A Retrospective Cohort Study
|